Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing alfuzosin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alfuzosin hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alfuzosin hydrochloride 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alfuzosin hydrochloride m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alfuzosin hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alfuzosin hydrochloride 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alfuzosin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alfuzosin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alfuzosin hydrochloride 2.5 mg oral tablet |
Has precise active ingredient |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alfuzosin hydrochloride 10 milligram and dutasteride 500 microgram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely alfuzosin hydrochloride 10 milligram and dutasteride 500 microgram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alfuzosin hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |